Kerry Lebenger, MD
Allergy & Immunology · Berkeley Heights, NJNPI 1982606471
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $69,048 of the $76,317 with a category attached, or 90.5%. 12 manufacturers reported payments, led by AstraZeneca at 42.0% of the total. Among allergy & immunology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $620.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$32K
- Optinose US, Inc.$22K
- Sanofi$8K
- Regeneron Healthcare Solutions, Inc.$7K
- ARS Pharmaceuticals Operations, Inc.$5K
- Amgen$2K
- plus $367 from 6 others
Across 3 payments — averaging $614.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alk-abello, Inc$1K
- Roche Products Limited$513
What the payments were for
- Consulting fees$2,0003%
- Speaking & faculty fees$69,04890%
- Travel & lodging$2,0243%
- Food & beverage$3,2154%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $32,022 |
| Optinose US, Inc. | 33 | $22,304 |
| Sanofi | 10 | $7,645 |
| Regeneron Healthcare Solutions, Inc. | 18 | $6,734 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $5,281 |
| Amgen | 2 | $1,964 |
| Pharming Healthcare, Inc. | 1 | $124 |
| Alk-abello, Inc | 1 | $106 |
| Genentech USA, Inc. | 1 | $97 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$76,317 in reported general payments places this provider in the 90th percentile of 135 allergy & immunology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $42,124 |
| Breo ElliptaFluticasone/Vilanterol | 36 | $32,078 |
| Zileuton ErZileuton | 13 | $26,620 |
| XhanceFluticasone Propionate | 14 | $12,915 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 91 | $12,518 |
| DuleraMometasone/Formoterol | 11 | $6,994 |
| XareltoRivaroxaban | 13 | $6,153 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $4,296 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $3,717 |
| Montelukast Sodium | 280 | $3,491 |
| Mometasone Furoate | 38 | $3,281 |
| Ipratropium Bromide | 67 | $2,069 |
| Desloratadine | 22 | $2,010 |
| Levocetirizine Dihydrochloride | 106 | $1,844 |
| Azelastine Hcl | 57 | $1,660 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $22,304 | $12,91514 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $18 | $3,71712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 135 allergy & immunology providers in New Jersey.
Other allergy & immunology in Berkeley Heights
- Ellen SherOcean$1M
- Peter RickettiTrenton$457K
- John KimMedford$339K
- Tina ZeccaLittle Silver$262K
- George BelecanechVoorhees$208K
- Jacqueline RossOcean$131K
- Shirin JadidiMendham$98K
- Mark WeinsteinBelleville$88K
- Joseph GrizzantiHawthorne$79K
- Lisa BariscianoFlorham Park$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.